58
X.-H. Zhong et al. / Phytochemistry Letters 10 (2014) 55–59
Table 3
Anhui University of Traditional Medicine. A voucher specimen (No.
Liu20120720) has been deposited at Kunming Institute of Botany,
Chinese Academy of Sciences.
Cytotoxicity data of the alkaloids (IC50
,
m
M).
MCF-7
Compd.
HeLa
SW480
4
4.52 ꢁ 0.42
8.10 ꢁ 0.36
1.67ꢁ 0.21
13.63 ꢁ 0.45
1.37 ꢁ 0.10
3.01 ꢁ 0.14
19.63 ꢁ 1.59
3.3. Extraction and isolation
5
2.52 ꢁ 0.12
Cisplatin
11.84 ꢁ 1.04
The dried whole-plant of G. multiflora (10 kg) was extracted
three times with 90% MeOH (25 L each). The extract was
partitioned between EtOAc and a 0.5% HCl solution three times.
The acidic water layer, adjusted to pH 9–10 with a 10% ammonia
solution, was extracted with EtOAc to give an alkaloidal extract
(34 g). The total alkaloid was subjected to a silica gel column
(CHCl3/acetone, 10:1 to 1:1) to give the five fractions I–V. Fraction I
(0.5 g) was separated by silica gel CC (petroleum ether/Me2CO,
4:1–1:1), then by HPLC, eluted with MeOH/H2O (60–75%), to give
vallesiachotamine (35.7 mg). Fraction II (1.2 g) was separated by
silica gel CC (petroleum ether/Me2CO, 2:1 to 1:1), to give a mixture
A. Fraction III (4.7 g) was subjected to a C18 silica gel column and
eluted with MeOH/H2O (2:5–4:5, v/v) to yield fraction III-1,
fraction III-2 and the mixture of compounds B. A and B were further
purified by RP-18 CC (MeOH/H2O, from 3:20 to 3:10, v/v) to yield
cantleyine (260.1 mg). Chitosenine (222.1 mg) was crystallized in
methanol from fraction III-1. Fraction III-1 (107.5 mg) was further
purified by HPLC (MeOH/H2O, from 50% to 60%). Fraction III-2
(1.2 g) was separated by a C18 column (MeOH/H2O, 2:5–13:20, v/
v) to afford fraction III-2-1 (19 mg) and fraction III-2-2 (27 mg).
Fraction III-2-1 and fraction III-2-2 were further purified by HPLC
(MeOH/H2O, from 52% to 63%) to yield 18-demethoxygardner-
amine (6.4 mg) and 18-demethoxygardfloramine (8.7 mg), respec-
tively. Fraction IV (19 g) was subjected to RP-18 (MeOH/H2O, from
1:5 to 4:5, v/v), yielding three subfractions (IV-1–IV-3). Fraction
IV-1 (5.4 g) was applied to MPLC (MeOH/H2O, 1:9-7:20, v/v) to
offer fraction IV-1-1 and fraction IV-1-2. Fraction IV-1-1 was
further purified by HPLC to yield 7 (22.4 mg), 4 (8.2 mg), Alkaloid M
that the C-19/C-20 double bond had the Z-configuration. Thus, 6
was named gardmutine F.
The 13C NMR and DEPT data of 7 were closed to those of
chitosenine with the exception of an additional downfield
methylene at dC 57.0 and the absence of a methyl signal at dC
13.0 (C-18) in chitosenine (Aimi et al., 1978). The ROESY
correlations of H-19 (dH 5.10) to H-15 (dH 2.13) in 7 indicated
the Z-configuration of the C-19/20 double bond. Thus, 7 was named
18-hydroxy-chitosenine.
Other known alkaloids were identified, such as vallesiachota-
mine (Djerassi et al., 1966), cantleyine (Massiot et al., 1992),
chitosenine (Sakai et al., 1975), 18-demethoxygardneramine (Aimi
et al., 1978), 18-demethoxygardfloramine (Sakai et al., 1987),
gardfloramine (Sakai et al., 1987), 18-demethylgardneramine
(Aimi et al., 1978), gardneramine (Aimi et al., 1978), N4-oxide
gardneramine (Sakm et al., 1977), Alkaloid M (Sakm et al., 1977),
Alkaloid N (Sakm et al., 1977), Alkaloid I (Sakm et al., 1977),
Alkaloid J (Sakm et al., 1977), bemethoxygardmultine (Sakai et al.,
1982), and gardmultine (Sakm et al., 1977) by comparison of their
NMR spectroscopic data with that in the literature. Alkaloids 1–6
are the first Gardneria alkaloids possessing the 7S-configuration.
The cytotoxicities of all of the alkaloids against three human cancer
cell lines were evaluated by using the MTT method. Only alkaloids
4 and 5 exhibited inhibitory effects against these three cell lines.
These are the first Gardneria alkaloids discovered with moderate
cytotoxicity (Table 3).
(10.5 mg), and
combined and purified by HPLC (MeOH/H2O: 50–70%) to yield
18-demethylgardneramine (5.8 mg), Alkaloid (3.7 mg),
2 (6.6 mg). Fractions IV-1-2 and IV-2 were
3. Experimental
N
3
3.1. General experimental procedures
(11.5 mg), 5 (21.7 mg), Alkaloid J (3.9 mg), Alkaloid I (39.6 mg),
and 1 (6.4 mg). Fraction IV-3 (6.2 g) was subjected to a C18 silica
gel column and eluted with MeOH/H2O (1:4–3:5, v/v) to give
fraction IV-3-1 (1.37 g) and fraction IV-3-2 (0.11 g). Fraction IV-3-1
was further purified by HPLC (MeOH/H2O: 55–75%) to yield
gardneramine (8.6 mg) and 6 (11.5 mg). Fraction IV-3-2 was
purified by HPLC (MeOH/H2O: 60–80%) to yield gardfloramine
(27.9 mg) and gardneramine (6.5 mg). Fraction V (3.9 g) was
subjected to RP-18 (MeOH/H2O, from 1:5 to 13:20, v/v), affording
to 2 subfractions (V-1–V-2). Subfraction V-1 and fraction V-2 were
further purified by HPLC (MeOH/H2O, from 70% to 80%) to yield
bemethoxygardmultine (2.5 mg) and gardmultine (3.3 mg), re-
Optical rotations were measured with an Horiba SEPA-300
polarimeter. UV spectra were obtained using a Shimadzu UV-
2401A spectrometer. IR spectra were obtained with a Bruker FT-IR
Tensor 27 spectrometer using KBr pellets. 1D and 2D NMR
spectroscopic data were run on a Bruker AVANCE III-600, DRX-500,
and AM-400 MHz spectrometer with TMS as an internal standard.
ESI–MS spectra were measured on a Bruker HTC/Esquire spec-
trometer, and HREIMS was recorded on a Waters Auto Premier
P776 spectrometer. Column chromatography (CC) was performed
on silica gel (200–300 mesh, Qingdao Marine Chemical, Ltd.,
Qingdao, People’s Republic of China), RP-18 gel (20–45
m
m, Fuji
spectively.
17
Silysia Chemical Ltd., Japan). Fractions were monitored by TLC (GF
254, Qingdao Haiyang Chemical Co., Ltd., Qingdao), and spots were
visualized by Dragendorff’s reagent. Medium-pressure liquid
chromatography was employed using a Buchi pump system coupled
with a C18-silica gel-packed glass column (15 mm ꢂ 230 mm and
26 mm ꢂ 460 mm, respectively). HPLC was performed using a
Waters 1525EF pumps coupled with an Xbridge/Sunfire analytical,
semipreparative, or preparative C18 column (150 mm ꢂ 4.6 mm,
150 mm ꢂ 10 mm, and 250 mm ꢂ 19 mm, respectively). The HPLC
system employed a Waters 2998 photodiode array detector and a
Waters fraction collector III.
Gardmutine A (1): White powder; [
a
]
ꢀ18.2 (c 0.14, MeOH);
D
UV (MeOH) lmax (log
e
) 313 (2.73), 256 (2.94), 203 (3.56) nm; IR
(KBr) nmax 3440, 2925, 1692, 1633, 1497, 1245 cmꢀ1
;
1H
(400 MHz) and 13C NMR (100 MHz) data (acetone-d6), see Tables
1 and 2, respectively; HREIMS m/z 400.1992 (calcd for C22H28N2O5
[M]+., 400.1998, error: 1.5 ppm).
17
Gardmutine B (2): White powder; [
UV (MeOH) lmax (log
(KBr)
a
]
ꢀ23.4 (c 0.12, MeOH);
D
e
) 313 (2.88), 253 (3.11), 203 (3.75) nm; IR
n
max 3435, 2930, 1690, 1633, 1498, 1247 cmꢀ1; 1H (400 MHz)
and 13C NMR (100 MHz) data (DMSO), see Tables 1 and 2,
respectively; positive ESIMS m/z 417 [M + H]+, HREIMS m/z
416.1956 (calcd for C22H28N2O6 [M]+., 416.1947, error: 2.2 ppm).
17
D
3.2. Plant material
Gardmutine C (3): Colorless oil; [
(MeOH) max (log
max 3440, 2925, 1703, 1640, 1489, 1244 cmꢀ1; 1H (600 MHz) and
13C NMR (150 MHz) data (DMSO), H 4.09 (1H, d, J = 7.8 Hz, H-10),
a
]
ꢀ32.4 (c 0.13, MeOH); UV
l
e) 313 (2.91), 252 (3.10), 203 (3.78) nm; IR (KBr)
The whole herbs of G. multiflora were collected from Yellow Mount,
Anhui Province, P.R. China and authenticated by Prof. Shou-Jin Liu,
n
d